Biden's Push to Make Some of the Most Expensive Prescription Drugs Cheaper : Consider This from NPR On Tuesday, the Biden administration released a list of 10 medications that it's planning to negotiate prices for Medicare in an effort to bring down the costs of some of the most expensive drugs. It's part of a reform included in the Inflation Reduction Act. Many on the list are life-saving drugs that treat diabetes, cancer and other major health problems.|

The new prices that the federal government will eventually negotiate for these prescription drugs won't actually go into effect until 2026, and that's only if it doesn't get tied up in court with drugmakers. Six pharmaceutical companies who have filed lawsuits against the administration are calling these provisions unconstitutional.

Juana Summers speaks with NPR's pharmaceuticals correspondent Sydney Lupkin and Deepa Shivaram at the White House about the battle lines being drawn between the Biden Administration and pharmaceutical companies.

Biden's Push to Make Some of the Most Expensive Prescription Drugs Cheaper

Biden's Push to Make Some of the Most Expensive Prescription Drugs Cheaper

  • Download
  • <iframe src="https://www.npr.org/player/embed/1196645393/1200115109" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

U.S. President Joe Biden speaks during an event promoting lower healthcare costs at the White House on Tuesday in Washington, DC. The Biden administration announced a list of the first ten medicines that will now have lower prices following negotiations with Medicare. Win McNamee/Getty Images hide caption

toggle caption
Win McNamee/Getty Images

U.S. President Joe Biden speaks during an event promoting lower healthcare costs at the White House on Tuesday in Washington, DC. The Biden administration announced a list of the first ten medicines that will now have lower prices following negotiations with Medicare.

Win McNamee/Getty Images

On Tuesday, the Biden administration released a list of 10 medications that it's planning to negotiate prices for Medicare in an effort to bring down the costs of some of the most expensive drugs. It's part of a reform included in the Inflation Reduction Act. Many on the list are life-saving drugs that treat diabetes, cancer and other major health problems.

The new prices that the federal government will eventually negotiate for these prescription drugs won't actually go into effect until 2026, and that's only if it doesn't get tied up in court with drugmakers. Six pharmaceutical companies who have filed lawsuits against the administration are calling these provisions unconstitutional.

Juana Summers speaks with NPR's pharmaceuticals correspondent Sydney Lupkin and Deepa Shivaram at the White House about the battle lines being drawn between the Biden Administration and pharmaceutical companies.

This episode was produced by Linah Mohammad, Brianna Scott and Erika Ryan. It was edited by Roberta Rampton, Scott Hensley and Adam Raney. Our executive producer is Sami Yenigun.